A prognostic signature, consisting of five genes (ACADVL, ACAT1, ACSL3, ADH4 and ECI1), was established based on 42 FAM genes, which showed good performance for the prognosis of HBV-associated HCC both in the TCGA cohort and the validation cohort. This evidence concerns the gene ECI1 and hepatocellular carcinoma.